Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
Current Cancer Drug Targets
|
May 14, 2010
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent
L Tentori, A Muzi, A S Dorio, et al.
European Journal of Immunology
|
November 2, 2016
B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients
Emiliano Marasco, Chiara Farroni, Simona Cascioli, et al.
Biomed Research International
|
June 6, 2014
Antitumor effects of saffron-derived carotenoids in prostate cancer cell models
Claudio Festuccia, Andrea Mancini, Giovanni Luca Gravina, et al.
Current Cancer Drug Targets
|
May 25, 2010
In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells
P Ulivi, C Arienti, W Zoli, et al.
Oncotarget
|
January 27, 2018
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR<sup>ser81</sup> and CDK1 signaling: biological implications for men treated with testosterone replacement therapy
Giovanni Luca Gravina, Francesco Marampon, Patrizia Sanità, et al.
Stem Cells and Development
|
July 19, 2014
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells
Maria Manuela Rosado, Maria Ester Bernardo, Marco Scarsella, et al.
Animals : an Open Access Journal From MDPI
|
November 25, 2023
The Oral Microbiome across Oral Sites in Cats with Chronic Gingivostomatitis, Periodontal Disease, and Tooth Resorption Compared with Healthy Cats
Jamie G Anderson, Connie A Rojas, Elisa Scarsella, et al.
Frontiers in Immunology
|
December 6, 2018
Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome
Chiara Farroni, Emiliano Marasco, Valentina Marcellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors
Carlo Leonetti, Marco Scarsella, Giuseppe Riggio, et al.
Frontiers in Immunology
|
April 12, 2021
Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders
Dario Didona, Luca Scarsella, Milad Fehresti, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
Current Cancer Drug Targets
|
May 14, 2010
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent
L Tentori, A Muzi, A S Dorio, et al.
European Journal of Immunology
|
November 2, 2016
B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients
Emiliano Marasco, Chiara Farroni, Simona Cascioli, et al.
Biomed Research International
|
June 6, 2014
Antitumor effects of saffron-derived carotenoids in prostate cancer cell models
Claudio Festuccia, Andrea Mancini, Giovanni Luca Gravina, et al.
Current Cancer Drug Targets
|
May 25, 2010
In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells
P Ulivi, C Arienti, W Zoli, et al.
Oncotarget
|
January 27, 2018
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR<sup>ser81</sup> and CDK1 signaling: biological implications for men treated with testosterone replacement therapy
Giovanni Luca Gravina, Francesco Marampon, Patrizia Sanità, et al.
Stem Cells and Development
|
July 19, 2014
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells
Maria Manuela Rosado, Maria Ester Bernardo, Marco Scarsella, et al.
Animals : an Open Access Journal From MDPI
|
November 25, 2023
The Oral Microbiome across Oral Sites in Cats with Chronic Gingivostomatitis, Periodontal Disease, and Tooth Resorption Compared with Healthy Cats
Jamie G Anderson, Connie A Rojas, Elisa Scarsella, et al.
Frontiers in Immunology
|
December 6, 2018
Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome
Chiara Farroni, Emiliano Marasco, Valentina Marcellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors
Carlo Leonetti, Marco Scarsella, Giuseppe Riggio, et al.
Frontiers in Immunology
|
April 12, 2021
Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders
Dario Didona, Luca Scarsella, Milad Fehresti, et al.
Page
of 19